mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.04 |
mRNA |
spautin-1 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.04 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.04 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.04 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.04 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.05 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.05 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.05 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.05 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.05 |